Over-expression of SEMA7A at both the transcriptomic and protein levels highlight it as a potential biomarker for further investigations and for application in clinical diagnostics, particularly for forecasting outcomes in ACC patients. The gene discussed is SEMA7A; the disease is adrenal cortex carcinoma.